Adam Yalin

Rehovot, M, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy.

Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy.

Journal: Cell
Published: April 02, 2025

Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols.

Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols.

Journal: Nature cancer
Published: September 03, 2023

Spatial and Temporal Mapping of Breast Cancer Lung Metastases Identify TREM2 Macrophages as Regulators of the Metastatic Boundary.

Spatial and Temporal Mapping of Breast Cancer Lung Metastases Identify TREM2 Macrophages as Regulators of the Metastatic Boundary.

Journal: Cancer discovery
Published: March 11, 2023

Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy.

Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy.

Journal: Science immunology
Published: March 03, 2023

Author Correction: Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling.

Author Correction: Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling.

Journal: Nature cancer
Published: November 14, 2022

Single-cell immunology: Past, present, and future.

Single-cell immunology: Past, present, and future.

Journal: Immunity
Published: November 04, 2021

Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling.

Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling.

Journal: Nature cancer
Published: October 11, 2021

LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma.

LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma.

Journal: Cell
Published: June 15, 2021

Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulation.

Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulation.

Journal: Immunity
Published: September 06, 2020

Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer.

Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer.

Journal: Cell
Published: January 16, 2020
Showing 1-10 of 10

Last Updated: 09/26/2026